Dmitry Enikeev Selected Research

Carcinoma (Carcinomatosis)

7/2022	Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study.
6/2022	Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder.
5/2022	Circulating Tumour DNA Is a Strong Predictor of Outcomes in Patients Treated with Systemic Therapy for Urothelial Carcinoma.
3/2022	Follow-up of the Urethra and Management of Urethral Recurrence After Radical Cystectomy: A Systematic Review and Proposal of Management Algorithm by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group.
1/2022	A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma.
1/2022	Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes.
1/2022	Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
11/2021	Expression Analysis and Mutational Status of Histone Methyltransferase KMT2D at Different Upper Tract Urothelial Carcinoma Locations.
11/2021	Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy.
11/2021	Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dmitry Enikeev Research Topics

Disease

19	Neoplasms (Cancer) 07/2022 - 01/2019
16	Carcinoma (Carcinomatosis) 07/2022 - 05/2020
12	Urinary Bladder Neoplasms (Bladder Cancer) 03/2022 - 10/2019
10	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2018
8	Non-Muscle Invasive Bladder Neoplasms 08/2022 - 10/2019
7	Renal Cell Carcinoma (Grawitz Tumor) 06/2022 - 11/2020
6	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 10/2020 - 01/2018
2	Urinary Incontinence 10/2022 - 01/2020
2	Inflammation (Inflammations) 06/2022 - 03/2022
2	Hyperplasia 03/2022 - 01/2021
2	COVID-19 01/2022 - 01/2021
2	Disease Progression 01/2022 - 01/2020
2	Lymphatic Metastasis 01/2022 - 11/2021
2	Kidney Neoplasms (Kidney Cancer) 01/2022 - 10/2021
2	Febrile Neutropenia 01/2021 - 01/2021
2	Anemia 01/2021 - 01/2021
2	Fatigue 01/2021 - 01/2021
2	Urinary Retention 01/2021 - 01/2021
2	Lower Urinary Tract Symptoms 01/2021 - 01/2021
1	Urologic Neoplasms (Urological Cancer) 05/2022
1	Hemorrhage 03/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Alopecia (Baldness) 01/2021
1	Constipation 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Urogenital Neoplasms 01/2021
1	Kidney Calculi (Kidney Stone) 01/2021
1	Neutropenia 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Infections 01/2021
1	Intraoperative Complications 11/2020
1	Urinary Calculi (Urinary Calculus) 11/2020
1	Adenoma (Adenomas) 12/2019
1	Adenocarcinoma 03/2019
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 12/2018

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2019
7	ThuliumIBA 03/2022 - 01/2018
4	AlbuminsIBA 03/2022 - 02/2021
4	GlobulinsIBA 03/2022 - 02/2021
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2021 - 10/2019
3	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2021
3	Phenobarbital (Luminal)FDA Link 01/2021 - 05/2020
3	Urokinase Plasminogen Activator ReceptorsIBA 10/2020 - 10/2019
3	Plasminogen Activators (Plasminogen Activator)IBA 10/2020 - 10/2019
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 01/2018
3	Biological ProductsIBA 10/2019 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 11/2019
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 11/2021
2	Cisplatin (Platino)FDA LinkGeneric 11/2021 - 01/2021
2	Serum AlbuminIBA 09/2021 - 02/2021
2	Alanine Transaminase (SGPT)IBA 06/2021 - 12/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2021 - 12/2020
2	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 11/2020 - 11/2019
2	Plasminogen Activator Inhibitor 1IBA 01/2020 - 10/2019
1	Hormones (Hormone)IBA 01/2022
1	atezolizumabIBA 01/2022
1	pembrolizumabIBA 01/2022
1	NivolumabIBA 01/2022
1	isopropyl cyanoacrylateIBA 01/2022
1	EndoglinIBA 01/2022
1	Histone MethyltransferasesIBA 11/2021
1	Viral RNAIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	taxaneIBA 01/2021
1	telomerase RNA (bTR)IBA 01/2021
1	ClaudinsIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Gemcitabine FDA Link 01/2021
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 05/2020
1	Fibrinolysin FDA Link 01/2020
1	SiliconIBA 11/2019
1	OligonucleotidesIBA 11/2019
1	BuffersIBA 11/2019
1	SolutionsIBA 11/2019

Therapy/Procedure

13	Therapeutics 05/2022 - 03/2019
9	Cystectomy 07/2022 - 01/2020
9	Lasers (Laser) 03/2022 - 10/2018
6	Nephrectomy 06/2022 - 11/2020
5	Neoadjuvant Therapy 07/2022 - 12/2020
5	Drug Therapy (Chemotherapy) 05/2022 - 01/2021
5	Immunotherapy 05/2022 - 05/2020
5	Prostatectomy (Retropubic Prostatectomy) 11/2021 - 01/2019
3	Transurethral Resection of Prostate (TURP) 01/2022 - 10/2018
3	Nephroureterectomy 11/2021 - 12/2020
3	Solid-State Lasers 10/2020 - 01/2018
2	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 03/2022 - 01/2021
2	Transurethral Resection of Bladder 01/2022 - 09/2021
1	Blood Transfusion (Blood Transfusions) 10/2022
1	Urinary Diversion (Ileal Conduit) 07/2022
1	Electrocoagulation (Electrocautery) 03/2022
1	Adjuvant Chemotherapy 01/2022
1	Percutaneous Nephrolithotomy 01/2021
1	Maintenance Chemotherapy 01/2021
1	Cryotherapy (Therapy, Cold) 01/2020
1	Operative Surgical Procedures 01/2020
1	Brachytherapy 01/2020
1	Catheters 01/2020